{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:10:22Z","timestamp":1791897022927,"version":"4.3.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"am","delay-in-days":330,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017141","name":"Samsung Medison Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["NRF-2019R1A5A2027340"],"award-info":[{"award-number":["NRF-2019R1A5A2027340"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["CRC-15-04-KIST"],"award-info":[{"award-number":["CRC-15-04-KIST"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Korea Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003653","name":"Korea National Institute of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010418","name":"IITP","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010418","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008783","name":"National Research Council of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008783","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.neurobiolaging.2022.02.012","type":"journal-article","created":{"date-parts":[[2022,2,27]],"date-time":"2022-02-27T09:23:03Z","timestamp":1645953783000},"page":"84-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Development of prediction models for distinguishable cognitive trajectories in patients with amyloid positive mild cognitive impairment"],"prefix":"10.1016","volume":"114","author":[{"given":"Seung Joo","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sook-Young","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Ju","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyemin","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0098-7592","authenticated-orcid":false,"given":"Duk L.","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seonwoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Won","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2022.02.012_bib0001","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jalz.2010.03.006","article-title":"Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans","volume":"6","author":"Aisen","year":"2010","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2022.02.012_bib0002","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/brain\/awh451","article-title":"The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study","volume":"128","author":"Amieva","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2022.02.012_bib0003","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13550-018-0456-7","article-title":"Centiloid scaling for quantification of brain amyloid with [(18)F]flutemetamol using multiple processing methods","volume":"8","author":"Battle","year":"2018","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.neurobiolaging.2022.02.012_bib0004","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1006376","article-title":"Alzheimer's Disease Neuroimaging, I. Modeling and prediction of clinical symptom trajectories in Alzheimer's disease using longitudinal data","volume":"14","author":"Bhagwat","year":"2018","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.neurobiolaging.2022.02.012_bib0005","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1212\/01.wnl.0000249117.23318.e1","article-title":"Mild cognitive impairment: long-term course of four clinical subtypes","volume":"67","author":"Busse","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2022.02.012_bib0006","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jagp.2015.06.001","article-title":"Alzheimer's Disease Neuroimaging, I. Trajectories of Neuropsychiatric Symptoms and Cognitive Decline in Mild Cognitive Impairment","volume":"24","author":"David","year":"2016","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2022.02.012_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212435","article-title":"Evaluating trajectories of episodic memory in normal cognition and mild cognitive impairment: Results from ADNI","volume":"14","author":"Ding","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2022.02.012_bib0008","first-page":"1104","article-title":"Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study","volume":"30","author":"Drzezga","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.neurobiolaging.2022.02.012_bib0009","first-page":"54","article-title":"Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy","author":"Efron","year":"1986","journal-title":"Statistical science"},{"key":"10.1016\/j.neurobiolaging.2022.02.012_bib0010","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1177\/0011000016658097","article-title":"Using group-based trajectory and growth mixture modeling to identify classes of change trajectories","volume":"44","author":"Frankfurt","year":"2016","journal-title":"The Counseling Psychologist"},{"key":"10.1016\/j.neurobiolaging.2022.02.012_bib0011","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1010920819831","article-title":"A simple generalisation of the area under the ROC curve for multiple class classification problems","volume":"45","author":"Hand","year":"2001","journal-title":"Machine learning"},{"key":"10.1016\/j.neurobiolaging.2022.02.012_bib0012","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","article-title":"Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study","volume":"5","author":"Hansson","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurobiolaging.2022.02.012_bib0013","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1212\/01.WNL.0000115115.98960.37","article-title":"Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain","volume":"62","author":"Ingelsson","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2022.02.012_bib0014","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/jmri.21049","article-title":"Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods","volume":"27","author":"Jack","year":"2008","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.neurobiolaging.2022.02.012_bib0015","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurobiolaging.2022.02.012_bib0016","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1093\/brain\/awq277","article-title":"Alzheimer's Disease Neuroimaging, I. Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease","volume":"133","author":"Jack","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2022.02.012_bib0017","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1212\/WNL.0b013e3181bc010c","article-title":"Alzheimer's Disease Neuroimaging, I. Relationships between biomarkers in aging and dementia","volume":"73","author":"Jagust","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2022.02.012_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2019.101941","article-title":"Alzheimer's Disease Neuroimaging, I. Prediction of fast decline in amyloid positive mild cognitive impairment patients using multimodal biomarkers","volume":"24","author":"Jang","year":"2019","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.neurobiolaging.2022.02.012_bib0019","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/0049124101029003005","article-title":"A SAS procedure based on mixture models for estimating developmental trajectories","volume":"29","author":"Jones","year":"2001","journal-title":"Sociological methods & research"},{"issue":"430","key":"10.1016\/j.neurobiolaging.2022.02.012_bib38","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1080\/01621459.1995.10476572","article-title":"Bayes factors","volume":"90","author":"Kass","year":"1995","journal-title":"Journal of the american statistical association"},{"key":"10.1016\/j.neurobiolaging.2022.02.012_bib0020","first-page":"e12007","article-title":"Amyloid duration is associated with preclinical cognitive decline and tau PET","volume":"12","author":"Koscik","year":"2020","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.1016\/j.neurobiolaging.2022.02.012_bib0021","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.mri.2013.04.008","article-title":"Fully-automated approach to hippocampus segmentation using a graph-cuts algorithm combined with atlas-based segmentation and morphological opening","volume":"31","author":"Kwak","year":"2013","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.neurobiolaging.2022.02.012_bib0022","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/ana.23908","article-title":"Alzheimer's Disease Neuroimaging, I. Comparing positron emission tomography imaging and cerebrospinal fluid measurements of beta-amyloid","volume":"74","author":"Landau","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurobiolaging.2022.02.012_bib0023","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/ana.23650","article-title":"Alzheimer's Disease Neuroimaging, I. Amyloid deposition, hypometabolism, and longitudinal cognitive decline","volume":"72","author":"Landau","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurobiolaging.2022.02.012_bib0024","doi-asserted-by":"crossref","first-page":"10468","DOI":"10.1038\/s41598-018-28881-1","article-title":"Prediction models of cognitive trajectories in patients with nonamnestic mild cognitive impairment","volume":"8","author":"Lee","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.neurobiolaging.2022.02.012_bib0025","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurobiolaging.2022.02.012_bib0026","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/00002093-199700112-00003","article-title":"Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study","volume":"11","author":"Mohs","year":"1997","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.neurobiolaging.2022.02.012_bib0027","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1037\/a0019502","article-title":"Heterogeneity of cognitive trajectories in diverse older persons","volume":"25","author":"Mungas","year":"2010","journal-title":"Psychol Aging"},{"key":"10.1016\/j.neurobiolaging.2022.02.012_bib0028","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000360229","article-title":"Group-based trajectory modeling: an overview","volume":"65","author":"Nagin","year":"2014","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/j.neurobiolaging.2022.02.012_bib0029","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1146\/annurev.clinpsy.121208.131413","article-title":"Group-based trajectory modeling in clinical research","volume":"6","author":"Nagin","year":"2010","journal-title":"Annu Rev Clin Psychol"},{"key":"10.1016\/j.neurobiolaging.2022.02.012_bib0030","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1212\/WNL.0b013e3181b23564","article-title":"Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study","volume":"73","author":"Okello","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2022.02.012_bib0031","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/nature08538","article-title":"Multimodal techniques for diagnosis and prognosis of Alzheimer's disease","volume":"461","author":"Perrin","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2022.02.012_bib0032","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1212\/WNL.0b013e3181cb3e25","article-title":"Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization","volume":"74","author":"Petersen","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2022.02.012_bib0033","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1007\/s00259-017-3749-6","article-title":"(18)F-Florbetaben PET beta-amyloid binding expressed in Centiloids","volume":"44","author":"Rowe","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.neurobiolaging.2022.02.012_bib0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132614","article-title":"Visualizing risk prediction models","volume":"10","author":"Van Belle","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2022.02.012_bib0035","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1002\/sim.5321","article-title":"Extending the c-statistic to nominal polytomous outcomes: the Polytomous Discrimination Index","volume":"31","author":"Van Calster","year":"2012","journal-title":"Stat Med"},{"key":"10.1016\/j.neurobiolaging.2022.02.012_bib0036","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3233\/JAD-2011-111694","article-title":"Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease","volume":"29","author":"van Rossum","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neurobiolaging.2022.02.012_bib0037","doi-asserted-by":"crossref","first-page":"5557","DOI":"10.1038\/s41598-018-23676-w","article-title":"Longitudinal outcomes of amyloid positive versus negative amnestic mild cognitive impairments: a three-year longitudinal study","volume":"8","author":"Ye","year":"2018","journal-title":"Sci Rep"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458022000331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458022000331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:42:02Z","timestamp":1759318922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458022000331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":38,"alternative-id":["S0197458022000331"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2022.02.012","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of prediction models for distinguishable cognitive trajectories in patients with amyloid positive mild cognitive impairment","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2022.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}